Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Soluble Kit receptor blocks stem cell factor bioactivity in vitro.

D D Dahlen1, N L Lin, Y C Liu

  • 1Department of Medicine, Division of Hematology, University of Washington, Harborview Medical Center, 325 9th Avenue, Seattle, WA 98104-2499, USA.

Leukemia Research
|April 13, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Efficacy analysis of the "six-step" robot-assisted subxiphoid extended thymectomy for myasthenia gravis].

Zhonghua yi xue za zhi·2026
Same author

[Clinical application and analysis of single-port laparoscopic and thoracoscopic McKeown esophagectomy for esophageal cancer].

Zhonghua yi xue za zhi·2021
Same author

[The relationship between IL-4 and trace elements in patients with allergic rhinitis of hui and han populations in Ningxia].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2018
Same author

[Study on anti-oxidase in smoking-related laryngeal squamous cell carcinoma].

Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery·2018
Same author

[Microdeletion and Mutation of Y Chromosome in Full Sibling Identification].

Fa yi xue za zhi·2017
Same author

[Mechanism of action of glucagon-like peptide-1 receptor agonist in promoting the apoptosis of hepatic stellate cells based on the extracellular signal-regulated kinase signaling pathway].

Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology·2017
Same journal

A multicenter real-world study of clinical outcomes in octogenarians and older patients with acute myeloid leukemia.

Leukemia research·2026
Same journal

FLAMSA versus FLAG-IDA as salvage therapy in adults with relapsed/refractory acute myeloid leukemia and acute lymphoblastic leukemia: A single-center real-world retrospective study.

Leukemia research·2026
Same journal

CD244 modulates bone marrow infiltrating CD8<sup>+</sup> T cells and serves as a prognostic and immunotherapeutic target in acute myeloid leukemia.

Leukemia research·2026
Same journal

Long-term remission and survival in older adults with IDH-mutated acute myeloid leukemia treated with IDH inhibitors.

Leukemia research·2026
Same journal

Real-world outcomes of plasmablastic lymphoma: Treatment approaches and survival outcomes in the PLASMABLAT-001 cohort.

Leukemia research·2026
Same journal

CRS and ICANS as class-level adverse event for CD20 ×CD3 bispecific T-cell engagers: A Bayesian analysis of a nationwide database.

Leukemia research·2026
See all related articles

Soluble Kit receptor can bind stem cell factor (SCF) with high affinity. This soluble Kit-Fc protein effectively blocks SCF

Area of Science:

  • Hematology
  • Molecular Biology
  • Cell Signaling

Background:

  • Stem cell factor (SCF) is crucial for hematopoietic cell development.
  • SCF exerts its functions through its receptor, Kit, which exists in both cell-surface and soluble forms.
  • The biological role of soluble Kit remains largely unknown.

Purpose of the Study:

  • To investigate whether soluble Kit can modulate stem cell factor (SCF) activity.
  • To characterize the binding affinity and inhibitory capacity of a soluble Kit fusion protein (Kit-Fc).

Main Methods:

  • Production and purification of a Kit-Fc fusion protein (extracellular domain of murine Kit fused to human IgG(1) Fc portion).
  • Assessment of Kit-Fc binding to iodinated SCF and transmembrane SCF using Scatchard analysis.

Related Experiment Videos

  • Evaluation of Kit-Fc's ability to inhibit SCF-stimulated proliferation of engineered murine mast cells (IC2-Kit).
  • In vitro analysis of Kit-Fc's effect on SCF-stimulated murine hematopoietic progenitor colony growth (erythroid and myeloid).

    • Main Results:

    • Kit-Fc demonstrated high-affinity binding to SCF (Kd 570 pM) and recognized transmembrane SCF.
    • Kit-Fc specifically inhibited SCF-stimulated proliferation of IC2-Kit cells, but not IL-3-stimulated growth.
    • Kit-Fc effectively blocked SCF-driven erythroid and myeloid hematopoietic colony formation, comparable to a neutralizing anti-Kit antibody (ACK2).
    • Kit-Fc did not inhibit colony growth stimulated by other growth factors like erythropoietin, IL-3, or GM-CSF.

    Conclusions:

    • Soluble Kit, as represented by Kit-Fc, binds stem cell factor (SCF) with high affinity.
    • Soluble Kit can specifically inhibit the bioactivity of SCF in stimulating hematopoietic progenitor cells.
    • These findings suggest a potential role for soluble Kit in modulating SCF signaling pathways in hematopoiesis.